Drug intelligence / Profile preview

pneumococcal vaccine + meningococcal vaccine + influenza vaccine

Development stage: Unknown
Lead developer: GSK
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Subcutaneous, Intranasal

Overview

This represents the concomitant administration of three separate vaccines: pneumococcal vaccine, meningococcal vaccine, and influenza vaccine. These vaccines can be administered during the same clinical visit but are not formulated as a single combination product. Each vaccine targets different pathogens: pneumococcal vaccines protect against Streptococcus pneumoniae infections, meningococcal vaccines protect against Neisseria meningitidis infections, and influenza vaccines protect against seasonal influenza viruses.

Beyond the preview

Go deeper on pneumococcal vaccine + meningococcal vaccine + influenza vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on pneumococcal vaccine + meningococcal vaccine + influenza vaccine.

Explore the full profile